Le Lézard
Classified in: Science and technology
Subject: Survey

New Research by Kroll Finds Over Two-Thirds of Global Executives and Risk Professionals Will Turn to Technology to Counter the Expected Increase in Financial Crime Risks


Kroll, the leading independent provider of global risk and financial advisory solutions, today released its 2023 Fraud and Financial Crime Report which found that 69% of global executives and risk professionals worldwide expect financial crime risks to increase over the next 12 months. Cybersecurity and data breaches are expected to be the primary drivers of increased financial crime risks, followed by financial pressures on organizations.

A survey of 400 senior leaders and risk professionals across four continents found that to counter a potential uptick in financial crime risks, two-thirds (67%) of respondents globally are planning to invest more in technology, with nearly half of the respondents (49%) citing data integrity as the biggest challenge when implementing new technologies.

David Lewis, Global Head of AML Advisory at Kroll, said, "The survey results show that firms face a perfect storm as financial crime risks increase and get more complex. They are not fully confident in the effectiveness of their defenses and will undoubtedly rush to embrace technology to solve all their problems."

Key findings from the eight countries represented in this survey include:

Haydn Jones, Global Head of Blockchain and Cryptocurrency Solutions at Kroll, commented: "In the face of this dynamically evolving landscape, the role of the compliance function remains more crucial than ever. As we look toward the future, the complex interplay between technologies of all types, geopolitics and financial crime means specialist skills will be required to navigate what is essentially a data-based future."

Methodology

Kroll commissioned a survey of 400 global executives and risk professionals in March 2023. Eight countries were represented in the survey with 50 participants from each?the U.S., Brazil, Mexico, the UK, France, Germany, the UAE and Singapore.

About Kroll

As the leading independent provider of risk and financial advisory solutions, Kroll leverages our unique insights, data and technology to help clients stay ahead of complex demands. Kroll's team of more than 6,500 professionals worldwide continues the firm's nearly 100-year history of trusted expertise spanning risk, governance, transactions and valuation. Our advanced solutions and intelligence provide clients the foresight they need to create an enduring competitive advantage. At Kroll, our values define who we are and how we partner with clients and communities. Learn more at kroll.com.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: